Pancreatic Cancer Research

ResearcherSüleyman Demirel ÜniversitesiActive in the last 2 years

Demet Kaçaroğlu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4920-0516; OpenAlex author ID A5035235295. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2024: 1 paper · 2025: 4 papers

Papers 5

  1. Dual facets of MSC-derived small EVs: regulatory insights into antitumor mechanisms in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s12032-025-02713-5↗
  2. Gold nanoparticles decorated FOLFIRINOX loaded liposomes for synergistic therapy of pancreatic cancer. First author DOI 10.1016/j.ijpharm.2024.125067↗
  3. TLR3-Dependent Polarization of Adipose-Derived Mesenchymal Stem Cells Regulates Pancreatic Cancer Cell Behavior in an Indirect Co-culture Model Co-author DOI 10.21203/rs.3.rs-8384537/v1↗
  4. Comparison of therapeutic potential of macrophage- or mesenchymal stem cell-derived exosomes in pancreatic cancer: An updated review. Co-author DOI 10.4252/wjsc.v17.i8.107400↗
  5. Anti-tumorigenic effects of naive and TLR4-primed adipose-derived mesenchymal stem cells on pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1002/cam4.6964↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Seher Yaylacı · 3 shared papers, 2024–2025 · strength 1.15
  2. Nilgün Gürbüz · 2 shared papers, 2024–2025 · strength 0.90
  3. Alper Murat Ulaşlı · 1 shared paper, 2025 · strength 0.42
  4. Nihal Aydoğan · 1 shared paper, 2025 · strength 0.37
  5. Emine Yaren Yilmaz · 1 shared paper, 2025 · strength 0.37

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.